UBS Group
FBT icon

UBS Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

UBS Group’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.9M Buy
205,511
+145
+0.1% +$31.2K 0.01% 1725
2026
Q1 		$41.2M Buy
205,366
+18,278
+10% +$3.78M 0.01% 1842
2025
Q4 		$38.6M Buy
187,088
+26,800
+17% +$5.36M 0.01% 1899
2025
Q3 		$28.7M Sell
160,288
-64
-0% -$10.9K ﹤0.01% 2178
2025
Q2 		$25.9M Sell
160,352
-40,894
-20% -$6.51M ﹤0.01% 2111
2025
Q1 		$34.2M Buy
201,246
+7,223
+4% +$1.25M 0.01% 1823
2024
Q4 		$32.2M Sell
194,023
-4,782
-2% -$817K 0.01% 1859
2024
Q3 		$34.2M Sell
198,805
-1,483
-0.7% -$245K 0.01% 1417
2024
Q2 		$30.8M Sell
200,288
-32,242
-14% -$4.84M 0.01% 1357
2024
Q1 		$35.8M Buy
232,530
+3,607
+2% +$550K 0.01% 1266
2023
Q4 		$36.2M Sell
228,923
-39,104
-15% -$5.62M 0.01% 1177
2023
Q3 		$39.2M Sell
268,027
-8,908
-3% -$1.36M 0.01% 1001
2023
Q2 		$42.4M Sell
276,935
-78,643
-22% -$12.3M 0.01% 924
2023
Q1 		$55.1M Sell
355,578
-30,388
-8% -$4.77M 0.02% 727
2022
Q4 		$59.5M Buy
385,966
+45,536
+13% +$6.72M 0.02% 717
2022
Q3 		$44.9M Buy
340,430
+11,181
+3% +$1.57M 0.02% 745
2022
Q2 		$44.6M Buy
329,249
+27,955
+9% +$3.85M 0.02% 787
2022
Q1 		$44.9M Sell
301,294
-25,826
-8% -$3.82M 0.02% 907
2021
Q4 		$53M Sell
327,120
-56,541
-15% -$9.14M 0.02% 923
2021
Q3 		$63.7M Buy
383,661
+1,034
+0.3% +$177K 0.02% 742
2021
Q2 		$66M Sell
382,627
-13,549
-3% -$2.24M 0.02% 698
2021
Q1 		$63.6M Sell
396,176
-27,414
-6% -$4.69M 0.02% 700
2020
Q4 		$71.2M Sell
423,590
-35,932
-8% -$5.83M 0.02% 615
2020
Q3 		$72.3M Sell
459,522
-12,753
-3% -$2.08M 0.03% 500
2020
Q2 		$79.2M Buy
472,275
+85,471
+22% +$13.4M 0.03% 435
2020
Q1 		$50.7M Sell
386,804
-5,518
-1% -$786K 0.02% 534
2019
Q4 		$58.3M Sell
392,322
-118,417
-23% -$16.3M 0.02% 690
2019
Q3 		$63.2M Sell
510,739
-208,938
-29% -$27.8M 0.02% 574
2019
Q2 		$101M Buy
719,677
+2,322
+0.3% +$320K 0.04% 394
2019
Q1 		$108M Buy
717,355
+129,065
+22% +$18.6M 0.04% 372
2018
Q4 		$73.1M Sell
588,290
-15,146
-3% -$2.07M 0.03% 459
2018
Q3 		$95.6M Buy
603,436
+186,653
+45% +$28.2M 0.04% 420
2018
Q2 		$58.4M Buy
416,783
+24,069
+6% +$3.3M 0.03% 580
2018
Q1 		$52.2M Buy
392,714
+11,031
+3% +$1.51M 0.02% 618
2017
Q4 		$47.5M Buy
381,683
+12,165
+3% +$1.5M 0.02% 699
2017
Q3 		$45.8M Buy
369,518
+23,581
+7% +$2.79M 0.02% 633
2017
Q2 		$39.5M Buy
345,937
+39,062
+13% +$4.2M 0.02% 682
2017
Q1 		$32.3M Buy
306,875
+62,572
+26% +$6.27M 0.02% 744
2016
Q4 		$22.2M Buy
244,303
+11,094
+5% +$1.04M 0.01% 957
2016
Q3 		$23.3M Sell
233,209
-3,381
-1% -$332K 0.01% 890
2016
Q2 		$21.2M Sell
236,590
-20,008
-8% -$1.84M 0.01% 902
2016
Q1 		$22.5M Sell
256,598
-733,131
-74% -$64.6M 0.02% 815
2015
Q4 		$112M Sell
989,729
-501
-0.1% -$53.9K 0.07% 272
2015
Q3 		$100M Buy
990,230
+38,960
+4% +$4.63M 0.07% 278
2015
Q2 		$118M Sell
951,270
-44,266
-4% -$5.34M 0.08% 272
2015
Q1 		$118M Buy
995,536
+93,474
+10% +$10.6M 0.08% 259
2014
Q4 		$92M Buy
+902,062
New +$88.1M 0.06% 315

Other funds holding FBT

First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return
NP
Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return

UBS Group's FBT Position: Q2 2026 in Review

UBS Group increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 0.07% in Q2 2026, buying an estimated $31.2K and bringing the position to 205,511 shares worth $50.9M. The position accounts for 0.01% of the portfolio, ranked #1725.

UBS Group first reported a position in FBT in Q4 2014 and has held it in 47 quarters since. The position peaked at $118M in Q2 2015. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • UBS Group held 205,511 shares of First Trust NYSE Arca Biotechnology Index Fund worth $50.9M as of Q2 2026.
  • UBS Group bought 145 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $31.2K.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of UBS Group's portfolio in Q2 2026, its #1725 holding.
  • UBS Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's First Trust NYSE Arca Biotechnology Index Fund position peaked at $118M in Q2 2015.
  • 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.